GUTS

FRACTYL HEALTH, INC.

Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001572616 Healthcare & Medical Devices

$1.08 −0.05 (−4.42%)

Oct 23 4:00 PM ET · prev $1.13

Market cap

$15.0M

Nano cap

Consensus

Buy

85% Buy or better · 13 analysts

Median target

🔒 Subscribers only

1 year

−93.5%

from $16.56 · Oct 24

30 days

−80.9%

from $5.64

52-week range

$1.08–28.44

at the low

Avg volume 20D

1.08M

Oct 16 spike 15.10M

Short interest

2.15M

≈16.2% of shares · −20.3%

Days to cover

1.2

at average volume

Insider net

+$167.3K

5 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BULLISH 5 reports · 90 days

Balance 0 bearish · 2 bullish · 1 mixed · 2 neutral oldest → newest, height = score

Avg score

·High conf. 4/5

Strongest BULLISH Fractyl Health reported positive topline six-month results from the REMAIN-1 pivotal study of its Revita DMR…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

B Jun 8 to Jun 12 3 days of insider buys: $127.4K by 5 insiders, avg $0.7430
A Jul 1 Craig-Hallum initiates
R Jul 15 Fractyl Health reported positive one-year results from the REMAIN-1…
R Aug 10 Fractyl Health reported a Q2 2026 net loss of $25.5M vs $27.9M a yea…
B Sep 14 1 insider buy $39.9K at $0.6185
E Oct 2 Trading halt: Trading Halt: GUTS — T1 (News Pending)
R Oct 16 Fractyl Health reported positive topline six-month results from the…
R Oct 22 Fractyl Health is restructuring to focus entirely on its Revita devi…

Signal stack

Where each data set points today.

InsidersBULLISH

5 insiders bought $167.3K at an average $0.7089. No open-market sales. Price is 52% above their cost.
InstitutionsBULLISH

Q2 2026: 7 added (0 new), 3 trimmed or exited.
AnalystsBULLISH

11 of 13 rate it Buy or better.
Short sellersCOVERING

Short interest −20.3% to 2.15M shares. 1.2 days to cover, ≈16.2% of shares.
TrendDOWNTREND

83% below its 50-day average. New closing low $1.08 on Oct 23.
SocialQUIET

No Reddit mentions this week. Last mention Oct 16.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
BANK OF AMERICA CORP /DE/	DOUBLED	6,034,147	$4.8M
JANE STREET GROUP, LLC	DOUBLED	1,731,622	$1.4M
MARSHALL WACE, LLP	ADD	1,080,667	$853.7K
Brevan Howard Capital Management LP	DOUBLED	916,321	$719.3K
GOLDMAN SACHS GROUP INC	DOUBLED	175,864	$139.7K
RENAISSANCE TECHNOLOGIES LLC	DOUBLED	122,200	$97.1K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	NEAR_EXIT	15,132	$12.0K
BARCLAYS PLC	NEAR_EXIT	1,865	$1.5K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts

Buy 85% rate it Buy or better

Strong Buy4Buy7Hold2Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 20, 2026	Canaccord Genuity MAINTAIN	MAINTAIN	Buy
Oct 19, 2026	Morgan Stanley MAINTAIN	MAINTAIN	Equal-Weight
Jul 1, 2026	Craig-Hallum INITIATE	INITIATE	Buy
Jun 4, 2026	HC Wainwright & Co. REITERATE	REITERATE	Buy

Insider ledger

Form 4

$167.3K

bought · 5 insiders

sold · 0 insiders

+52.3%

vs their $0.7089 cost

Date	Insider	Type	Value
Sep 14, 2026	BRADLEY WILLIAM Director	BUY	$39.9K
Jun 12, 2026	Royan Ajay Director	BUY	$19.6K
Jun 10, 2026	Rajagopalan Harith Chief Executive Officer	BUY	$18.3K
Jun 10, 2026	Elia Marc Director	AWARD	22,500 sh
Jun 10, 2026	MEANWELL CLIVE Director	AWARD	22,500 sh
Jun 10, 2026	Conaway Samuel Director	AWARD	22,500 sh
Jun 10, 2026	Sheffield Ian Director	BUY	$25.5K
Jun 10, 2026	Sheffield Ian Director	AWARD	22,500 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data — subscribers only
Next Q	🔒 Fresh data — subscribers only
Current FY	🔒 Fresh data — subscribers only
Next FY	🔒 Fresh data — subscribers only